News from CNBC Business
What is your interest today?
- ABC News Business
- BBC Business
- Business Insider Markets
- CBC Business
- City A.M.
- CNBC Business
- CoinDesk
- Cointelegraph
- Crypto News
- CryptoSlate
- Decrypt
- Economic Times Markets
- Euronews Business
- Financial Post Top Stories
- Financial Times
- Finextra Crypto
- Finextra Market
- Finextra Wealth
- Globe and Mail Investing
- Investing.com Global Markets
- Investing.com Global Mkts
- Investopedia
- Kiplinger
- MarketWatch MarketPulse
- MarketWatch Top Stories
- Quartz
- Sky News Money
- Sydney Morning Herald Biz
- Sydney Morning Herald Business
- TechCrunch Fintech
- The Block
- The Guardian – Business
- WSJ Markets News
Trump advisers defend tariffs amid legal fight, insisting they're 'not going away'
The ongoing legal dispute creates uncertainty around the evolving tariff policies, which have significantly impacted international trade and market stability since their implementa...
Read Full Article →Goolsbee says Fed now has to wait longer before moving rates because of trade policy uncertainty
The Federal Reserve is expected to delay any adjustments to interest rates as ongoing uncertainties in trade policy create a more cautious environment for monetary decision-making.
Read Full Article →35-year-old in Nashville may have to move family business overseas due to Trump tariffs: 'We can't d...
The Nashville-based loudspeaker company faces potential relocation abroad as increased import costs from new tariffs threaten to significantly raise production expenses.
Read Full Article →Fed holds rates steady as it notes rising uncertainty and stagflation risk
The Federal Reserve's decision to maintain current interest rates reflects caution amid economic instability and potential inflation, highlighting concerns about trade policies inf...
Read Full Article →Trump signs order to boost domestic drug manufacturing as pharma tariffs loom
The directive aims to enhance domestic production of medications, potentially reducing reliance on imports and impacting the cost structure of pharmaceuticals in the U.S. market.
Read Full Article →